Peregrine Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $9.8M | 795k | 12.35 |
| 2024-09-30 | $2.1M | 185k | 11.38 |
| 2024-06-30 | $1.3M | 177k | 7.14 |
| 2024-03-31 | $2.2M | 327k | 6.70 |
| 2023-12-31 | $1.7M | 261k | 6.50 |
| 2023-09-30 | $510k | 54k | 9.44 |
| 2023-06-30 | $1.2M | 87k | 13.97 |
| 2023-03-31 | $1.4M | 76k | 18.76 |
| 2022-12-31 | $2.8M | 204k | 13.77 |
| 2022-09-30 | $571k | 25k | 23.26 |
| 2022-06-30 | $876k | 38k | 23.26 |
| 2022-03-31 | $4.2M | 208k | 20.37 |
| 2021-12-31 | $4.5M | 160k | 27.78 |
| 2021-09-30 | $2.9M | 133k | 21.56 |
| 2021-06-30 | $1.9M | 76k | 25.64 |
| 2021-03-31 | $576k | 32k | 18.21 |
| 2020-12-31 | $98k | 8.5k | 11.59 |
| 2020-06-30 | $117k | 18k | 6.55 |
| 2020-03-31 | $173k | 34k | 5.12 |
| 2019-12-31 | $557k | 73k | 7.67 |
| 2019-09-30 | $184k | 35k | 5.31 |
| 2019-06-30 | $103k | 19k | 5.56 |
| 2019-03-31 | $44k | 10k | 4.28 |
| 2018-12-31 | $156k | 38k | 4.12 |
| 2018-09-30 | $209k | 30k | 6.87 |
| 2018-06-30 | $86k | 22k | 3.96 |
| 2018-03-31 | $8.4k | 2.9k | 2.94 |